Back to XERS
Rosalind Advisors, Inc. → XERS
Rosalind Advisors, Inc. XERS Position History
Xeris Biopharma Holdings, Inc. • Healthcare
Quarters held
4
Latest value
$24.7M
Q3 2026
Peak value
$24.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $16.6M |
| Q1 2026 | $18.7M |
| Q2 2026 | $23M |
| Q3 2026 | $24.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $24.7M | 2.58M | — | — |
| Q2 2026 | $23M | 2.91M | — | — |
| Q1 2026 | $18.7M | 3.23M | — | — |
| Q4 2025 | $16.6M | 2.11M | — | — |